pharma · Advanced Non Small Cell Lung Cancer
Yongchang Zhang
Yongchang Zhang is a pharma organization headquartered in CN. Primary therapeutic focus areas include Advanced Non Small Cell Lung Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent recor
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Toripalimab
Phase 2 · small molecule · Advanced Non Small Cell Lung Cancer
Toripalimab for Advanced Non Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Yongchang Zhang with 1 ClinicalTrials.gov record(s).
Internal code TOGATHER
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Yongchang Zhang
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced Non Small Cell Lung Cancer
- Status
- completed
- Trials
- 1